Sorrento Therapeutics Says $1B Bid Is Too Low
Sorrento Therapeutics on Monday rejected a takeover offer from an unnamed private equity fund that valued the biopharmaceutical company at almost $1 billion, contending that the offer from its latest suitor...To view the full article, register now.
Already a subscriber? Click here to view full article